prednisone and ustekinumab treatment

DRUG2 trials

Sponsors

Centre Hospitalier Universitaire Dijon

Conditions

Patients Relapsing Refractory Giant Cell ArteritisPatients With Newly Diagnosed Active NISU

Phase 2

Ustekinumab for the Treatment of Relapse of Refractory Giant Cell Arteritis

CompletedNCT03711448

Centre Hospitalier Universitaire DijonPatients Relapsing Refractory Giant Cell Arteritis

Start: 2019-01-07End: 2024-09-11Updated: 2024-10-04

A Multicenter Phase 2 Single-arm Proof-of-concept Trial to Assess the Efficacy and Safety of Ustekinumab in Association With Prednisone for the Treatment of Non-infectious Severe Uveitis (NISU)

TerminatedNCT03847272

Centre Hospitalier Universitaire DijonPatients With Newly Diagnosed Active NISU

Start: 2019-08-01End: 2023-10-25Updated: 2024-01-12